CRISPR-Cas System: Next Generation Genome Editing Tool

Autores/as

  • Monika . RESEARCH SCHOLAR
  • Rahul Kumar Meena
  • Leela Wati

Resumen

CRISPR-Cas system provides sequence specific adaptive immunity against phages and mobile genetic elements. Resistance is acquired following phage infection or plasmid uptake when short specific sequence is added into CRSIPR array. This complex guides cRNA to target complementary DNA fragments and target its degradation. CRISPR array is then transcribed and processed into cRNA which forms complex with cas protein. The ability of CRISPR-Cas system to induce site specific DNA breaks makes it suitable candidate for genome editing. Although CRISPR-Cas genome editing is relatively unexplored and under-represented in eukaryotic systems, but recent work in CRISPR-Cas genome editing all over the world provides valuable insights for widespread future applicability of it i.e. genetically modified plants, therapeutic design, gene surgery, fuel, animal model and genetic variations. This review emphasizes on molecular events involved in CRISPR-Cas system and recent progress in applicability of this system in genome editing.  Keywords: CRISPR-Cas, genome editing, PAM, acquired immunity, cRNACite this Article Monika, Rahul Kumar Meena, Leela Wati. CRISPR-Cas System: Next Generation Genome Editing Tool. Research & Reviews: A Journal of Biotechnology. 2016; 6(2): 10–16p.

Biografía del autor/a

  • Monika ., RESEARCH SCHOLAR
    DEPARTMENT OF MICROBIOLOGY CCS HAU HISAR AND RESEARCH SCHOLAR

Descargas

Publicado

2016-09-05

Número

Vol. 6 Núm. 2 (2016)

Sección

Review Articles

Licencia

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.